{"url_path":"/sec/galt/10-q/2026/item-2","section_key":"item-2","section_title":"Item 2 Unregistered Sales of Equity Securities and Use of Proceeds","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1133416/0001140361-26-021495-index.html","accession_number":"0001140361-26-021495","cik":"0001133416","ticker":"GALT","issuer_name":"GALECTIN THERAPEUTICS INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1133416/0001140361-26-021495-index.html","primary_entity_key":"0001133416","primary_entity_name":"GALECTIN THERAPEUTICS INC"},"word_count":12,"has_tables":true,"body_markdown":"Item 2.\n\nUnregistered Sales of Equity Securities and Use of Proceeds\n\n \n\nNone"}